Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Antiviral Res ; 18(3-4): 327-40, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1416911

ABSTRACT

Mucosal resistance to infection with lactate dehydrogenase-elevating virus (LDV) has been previously demonstrated, and the LDV system presents an important murine model for the study of mucosal barriers to viral infection. In the present study, duodenal molecules were isolated from normal mice which had potent virucidal activity, when tested against LDV as well as canine herpes, canine hepatitis, Semliki forest, and visna viruses. The virucidal activity was demonstrated to be non-immune in nature, and was present in apparently non-enzymatic protein molecules, having a molecular mass of between 10-100 kDa by membrane filtration and 10-17 kDa by gel filtration. The anti-LDV activity of these molecules was suppressed by anti-duodenum antibodies in vitro, and in vivo studies suggested a possible protective role for the anti-viral molecules. We conclude that the normal mouse duodenum contains potent virucidal molecules, which are of interest to the study of biological and molecular mechanisms of viral resistance.


Subject(s)
Antiviral Agents/pharmacology , Duodenum/chemistry , Lactate dehydrogenase-elevating virus/drug effects , Tissue Extracts/pharmacology , Animals , Female , Mice , Tissue Extracts/chemistry
2.
Antiviral Res ; 15(1): 77-83, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1903623

ABSTRACT

The murine lactate dehydrogenase-elevating virus (LDV) was used to study the effects of prostaglandin-acting agents on mucosal resistance to virus infection. Mice treated with non-steroidal anti-inflammatory drugs (NSAIDs) prior to oral exposure to LDV demonstrated a reduction in the mucosal barrier to LDV infection. Histological studies indicated that these NSAID effects were not a result of gross or microscopic tissue damage. The effects of two NSAIDs, indomethacin and diclofenac, were inhibited by co-treatment of mice with misoprostol, a synthetic PGE1 analog. The ability of misoprostol to modulate NSAID effects was not due to direct antiviral activity or to actions on LDV-permissive macrophages. These results show that the mammalian mucosal barrier to virus infection is prostaglandin-sensitive, and provide a model for the study of resistance to viral infection.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antiviral Agents/pharmacology , Alprostadil/analogs & derivatives , Alprostadil/pharmacology , Animals , Aspirin/pharmacology , Diclofenac/pharmacology , Female , Indomethacin/pharmacology , Lactate dehydrogenase-elevating virus/drug effects , Mice , Mice, Inbred Strains , Misoprostol , Virus Diseases/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...